首页> 外文OA文献 >Prognostic Significance of Peripheral T‐Cell Subsets in Laryngeal Squamous Cell Carcinoma
【2h】

Prognostic Significance of Peripheral T‐Cell Subsets in Laryngeal Squamous Cell Carcinoma

机译:喉鳞状细胞癌外周T细胞亚群的预后意义

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objectives The role of the immune system in head and neck squamous cell carcinoma is controversial. The aim of our study was to analyze full blood counts and distribution of T cell subsets in patients affected by laryngeal squamous cell cancer (LSCC) and their association with clinical variables and survival. Study design Retrospective study. Methods We analyzed the levels of platelets, lymphocytes, and neutrophils, as well as the CD4+, CD8+, and CD3+ T‐cell subpopulations by cytofluorometry in LSCC patients. A cohort of healthy patients was used as control group. The disease‐specific survival (DSS) was considered as survival outcome. Results Sixty‐five LSCC patients and 48 controls were enrolled. In LSCC patients, neutrophils were higher than in the healthy group (P < .0001). The neutrophil‐to‐lymphocyte ratio (NLR) and the platelet‐to‐lymphocyte ratio (PLR) were both higher in LSCC patients (P < .0001). In patients treated for recurrent disease, the CD8+/CD3+ ratio was increased (P = .02), while the CD4+/CD8+ (P = .03) and CD4+/CD3+ (P = .04) ratios were lower. In patients with lymph node metastases, leukocytes (P = .03), CD3+ (P = .04), and CD4+ (P = .0098) were all higher. Among Stages III‐IV patients, low lymphocyte and low leukocyte count were associated with worse DSS. Conclusion Our data demonstrate that NLR and PLR are significantly increased in LSCC. Lower CD4+/CD8+ and CD3+/CD8+ ratios are related to recurrent disease and a higher level of CD3+ and CD4+ is associated with nodal metastasis. Level of Evidence 4
机译:目标在头颈部鳞状细胞癌免疫系统的作用是有争议的。我们研究的目的是分析全血细胞计数和T细胞亚群的分布受喉鳞状细胞癌(LSCC)与临床变量和生存协会的病人。研究设计回顾性研究。方法我们分析了血小板,淋巴细胞和中性粒细胞的喉癌患者的水平,还有CD4 +,CD8 +和CD3 + T细胞亚群的cytofluorometry。健康的患者队列作为对照组。这种疾病特异性生存率(DSS)被认为是生存结果。结果68个喉癌患者和48名对照者。喉癌患者,中性粒细胞比在健康组(P <0.0001)高。嗜中性粒细胞对淋巴细胞的比例(NLR)和血小板对淋巴细胞的比例(PLR)为喉癌患者(P <0.0001)二者更高。在用于复发性疾病治疗的患者中,CD8 + / CD3 +比例增加(P = 0.02),而CD4 + / CD8 +(P = 0.03)和CD4 + / CD3 +(P = 0.04)的比率较低。患者淋巴结转移,白细胞(P = 0.03),CD3 +(P = 0.04),和CD4 +(P = 0.0098)均较高。在阶段III-IV的患者,低淋巴细胞和低白细胞计数用DSS恶化有关。结论:我们的数据表明,NLR和PLR喉癌是显著上升。较低的CD4 + / CD8 +和CD3 + / CD8 +的比例都与疾病复发和CD3 +和CD4 +与淋巴结转移相关联的更高的水平。证据水平4

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号